h&o,
I can certainly see why you'd avoid Avodart with your small prostate (so probably no BPH) and the risk of sexual SEs. I asked because they found no cancer on your f/u biopsies, and the only times I'd seen that happen before was when someone was taking Proscar or when there was a mistake. Because you were diligent in obtaining second opinions, we can probably rule out mistakes. It is all the more impressive because your prostate is small, so detection shouldn't be a big problem as it may be with large prostates.
I found the following report in this month's Urology journal very intriguing:
Active Surveillance of Very-low-risk Prostate Cancer in the Setting of Active Treatment of Benign Prostatic Hyperplasia With 5α-reductase Inhibitors.The surprise there, keeping in mind that it was only a small study, was that 54% of the men showed
no cancer on f/u biopsy.
The other thing I like about
5ARis is that they preferentially reduce the PSA caused by BPH so that one can get a cleaner read from PSA tracking. Of course, one loses the trend up to that point, but, arguably, that was never a useful trend in the first place. Increased sensitivity of PSA tracking to PC progression is an obvious benefit to an AS program.
Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate CancerWhen Beckman-Coulter makes PHI available in the US, I think that will be a huge benefit to men on AS programs because it is mostly sensitive to the type of PSA released by prostate cancer.
It sounds like you are on a very good AS program, and you are staying well on top of things. I hope you continue to have many years of living free of symptoms of treatment, and that you can live comfortably with the uncertainty as long as that is your desire.